Pyruvate Carboxylase Assay Kits

Assay Principle

Pyruvate carboxylase (PC) is a biotin-dependent enzyme, mitochondrial in most eukaryotes, found broadly across animals, fungi, and yeast as well as numerous bacteria (including well-characterized forms in Staphylococcus aureus and Rhizobium etli) that carboxylates pyruvate to oxaloacetate, making it both an anaplerotic entry point into the tricarboxylic acid cycle and the first rate-limiting enzyme of gluconeogenesis. A pyruvate carboxylase assay typically couples this carboxylation reaction to a linked dehydrogenase reaction that consumes or generates NAD(H), and enzyme activity is calculated from the resulting change in absorbance at 340 nm as the coupled reaction proceeds. Because the readout depends on a kinetic, coupled-enzyme format rather than a single-step color change, activity is typically calculated from the rate of absorbance change over a defined reaction window rather than a single endpoint reading.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are broadly validated across serum, plasma, animal tissue, and cell lysates, with reported sensitivity around 6 U/L and detection ranges extending to nearly 900 U/L, and assay times of around 35 minutes once samples are prepared. Because PC activity depends on biotin as a cofactor and is sensitive to sample handling, tissue and cell samples should be processed promptly and kept cold to preserve native enzyme activity, and dilution factors vary enormously by sample type, from roughly 90- to 110-fold for many tissue homogenates down to 2- to 4-fold for cultured cell lysates. Given this wide range, a short pretest dilution series is particularly worthwhile for any new sample type rather than assuming a published dilution factor will transfer directly.

Assay Kit Purchasing Considerations

Because the NAD(H)-coupled kinetic chemistry used to measure pyruvate carboxylase activity is reasonably standardized across suppliers, validated sample type coverage and reported precision, particularly inter-assay CV given the kinetic nature of the readout, are useful differentiators. For cancer metabolism research, where PC-mediated anaplerosis has been implicated in supporting tumor growth under certain metabolic conditions, confirming that a kit's validated cell line coverage and sensitivity are appropriate for the cell types under study is a practical consideration. Researchers studying inherited PC deficiency or other rare metabolic disorders should also confirm that a kit's detection range and sample type validation extend to the low-activity range relevant to patient-derived samples, since these can fall well below the activity levels typical of healthy tissue or standard cell lines. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.